SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime

被引:38
作者
Domingues, Renato [1 ]
Lippi, Alice [1 ,2 ]
Setz, Cristian [1 ,5 ]
Outeiro, Tiago F. [1 ,3 ,4 ]
Krisko, Anita [1 ]
机构
[1] Univ Med Ctr Goettingen, Ctr Biostruct Imaging Neurodegenerat, Dept Expt Neurodegenerat, Gottingen, Germany
[2] Univ Split, Fac Sci, Ctr Excellence Sci & Technol Integrat Mediterrane, Split, Croatia
[3] Max Planck Inst Expt Med, Gottingen, Germany
[4] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England
[5] Univ Med Ctr Goettingen, Dept Otolaryngol Head & Neck Surg, Gottingen, Germany
来源
AGING-US | 2020年 / 12卷 / 18期
关键词
aging; SARS-CoV-2; COVID-19; neuroinflammation; inflammaging; immunosenescence; CLINICAL CHARACTERISTICS; FUNCTIONAL RECEPTOR; INFLUENZA-VIRUS; AGE; CELL; CORONAVIRUS; INFECTION; SARS; DISEASE; SENESCENCE;
D O I
10.18632/aging.103989
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Pneumonia outbreak in the city of Wuhan, China, prompted the finding of a novel strain of severe acute respiratory syndrome virus (SARS-CoV-2). Here, we discuss potential long-term consequences of SARS-CoV-2 infection, and its possibility to cause permanent damage to the immune system and the central nervous system. Advanced chronological age is one of the main risk factors for the adverse outcomes of COVID-19, presumably due to immunosenescence and chronic low-grade inflammation, both characteristic of the elderly. The combination of viral infection and chronic inflammation in advanced chronological age might cause multiple detrimental unforeseen consequences for the predisposition and severity of neurodegenerative diseases and needs to be considered so that we can be prepared to deal with future outcomes of the ongoing pandemic.
引用
收藏
页码:18778 / 18789
页数:12
相关论文
共 101 条
  • [1] Nitric oxide and virus infection
    Akaike, T
    Maeda, H
    [J]. IMMUNOLOGY, 2000, 101 (03) : 300 - 308
  • [2] [Anonymous], 2020, JAMA NEUROL, DOI DOI 10.1001/JAMANEUROL.2020.0387
  • [3] Aylward Bruce, 2019, WHO CHINA JT MISSION, P2020
  • [4] Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
    Baker, Darren J.
    Wijshake, Tobias
    Tchkonia, Tamar
    LeBrasseur, Nathan K.
    Childs, Bennett G.
    van de Sluis, Bart
    Kirkland, James L.
    van Deursen, Jan M.
    [J]. NATURE, 2011, 479 (7372) : 232 - U112
  • [5] Cell senescence is an antiviral defense mechanism
    Baz-Martinez, Maite
    Da Silva-Alvarez, Sabela
    Rodriguez, Estefania
    Guerra, Jorge
    El Motiam, Ahmed
    Vidal, Anxo
    Garcia-Caballero, Tomas
    Gonzalez-Barcia, Miguel
    Sanchez, Laura
    Munoz-Fontela, Cesar
    Collado, Manuel
    Rivas, Carmen
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [6] Chronic microglial activation and progressive dopaminergic neurotoxicity
    Block, M. L.
    Hong, J. -S.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 1127 - 1132
  • [7] Bonafè M, 2001, EUR J IMMUNOL, V31, P2357, DOI 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.3.CO
  • [8] 2-O
  • [9] SARS-CoV2 entry and spread in the lymphatic drainage system of the brain
    Bostanciklioglu, Mehmet
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2020, 87 : 122 - 123
  • [10] Clinical and immunological features of severe and moderate coronavirus disease 2019
    Chen, Guang
    Wu, Di
    Guo, Wei
    Cao, Yong
    Huang, Da
    Wang, Hongwu
    Wang, Tao
    Zhang, Xiaoyun
    Chen, Huilong
    Yu, Haijing
    Zhang, Xiaoping
    Zhang, Minxia
    Wu, Shiji
    Song, Jianxin
    Chen, Tao
    Han, Meifang
    Li, Shusheng
    Luo, Xiaoping
    Zhao, Jianping
    Ning, Qin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) : 2620 - 2629